Christine M. Klaskin - 18 Jun 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
30 Jun 2025, 16:30:27 UTC
Prior SEC filing
20 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Christine Klaskin

Key filing fact

Christine M. Klaskin filed Form 4 for AGENUS INC (AGEN) on 30 Jun 2025.

Key facts

  • This page summarizes Christine M. Klaskin's Form 4 filing for AGENUS INC (AGEN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 30 Jun 2025, 16:30.

Change

  • Previous filing in this sequence was filed on 20 Jun 2025.
  • Current net transaction value: +$70,546.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001288123 Primary reporting owner

KLASKIN CHRISTINE M

Relationship
PFO & PAO
Address
C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON
Signature
/s/Christine Klaskin
Signature date
30 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGEN transaction

Common Stock

Award

Transaction value
$70,546
Shares
+15,782
Change %
+205%
Price
$4.47
Shares after
23,478
Date
18 Jun 2025
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects the executive's 2024 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 100% of the award released on July 18, 2025.

Footnote F2

$4.47 was the fair market value of Agenus Common Stock on June 18, 2025, the stock issuance date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .